Life Science’s Tangled Bank Of Business Models
The pharma industry is experiencing an explosion of new business models, more numerous and specialized than we're used to. Companies need to pick the right model and adapt faster and better than their competitors. Part 3 in a series from Brian Smith's new book, Darwin's Medicine.
You may also be interested in...
Where is our industry headed? Exactly where it is being pushed by what Charles Darwin called "immeasurably superior forces." Part 2 in a series from Brian Smith's new book, Darwin's Medicine.
In his forthcoming book, Darwin’s Medicine, Brian Smith argues that the emergence of new business models in the life science industry is explained by Darwin’s brilliant idea.
Professor Brian D Smith explores why so many medtech companies find it hard to create and offer their customers added-value services, and gives tips on how to overcome this difficulty to gain a competitive advantage